House Bill 5077 of 2023

rss
Previous Bill      Next Bill

Sponsors

Categories

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.

Documents

Bill Document Formatting Information
House Introduced Bill
Introduced bills appear as they were introduced and reflect no subsequent amendments or changes
As Passed by the House
The As Passed by the House version is the bill, as introduced, that includes any adoped House amendments

Analysis

Senate Fiscal Agency Analysis

SUMMARY OF HOUSE-PASSED BILL IN COMMITTEE (Date Completed: 6-18-24)
This document analyzes HB5077, HB5078

House Fiscal Agency Analysis

Summary as Introduced (10/26/2023)
This document analyzes HB5077, HB5078
Revised Summary as Reported from Committee (4/24/2024)
This document analyzes HB5077, HB5078

History

(House actions in lowercase, Senate actions in UPPERCASE)
Note: A page number of 0 indicates that the page number is coming soon
Date Journal Action
10/03/2023 HJ 79 Pg. 1877 introduced by Representative Curtis VanderWall
10/03/2023 HJ 79 Pg. 1877 read a first time
10/03/2023 HJ 79 Pg. 1877 referred to Committee on Health Policy
10/04/2023 HJ 80 Pg. 1896 bill electronically reproduced 10/03/2023
3/06/2024 HJ 22 Pg. 193 reported with recommendation without amendment
3/06/2024 HJ 22 Pg. 193 referred to second reading
4/18/2024 HJ 32 Pg. 280 read a second time
4/18/2024 HJ 32 Pg. 280 placed on third reading
4/24/2024 HJ 34 Pg. 314 read a third time
4/24/2024 HJ 34 Pg. 314 passed; given immediate effect Roll Call # 39 Yeas 96 Nays 11 Excused 0 Not Voting 1
4/24/2024 HJ 34 Pg. 314 transmitted
4/30/2024 SJ 39 Pg. 427 REFERRED TO COMMITTEE ON HEALTH POLICY